| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70f4d9874f66c3b7d4738051e49c24fb |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-4823
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-765
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L26-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-787
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 |
| filingDate |
2016-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6df55d855103b29e0aac6c33f4e56a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15ca0ad7ebd649ca0d1d4fb59f183c1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8c57565fc4be49bc5a1a73d865e6e6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_306fab2a5cb8e861d7a0f731590d7109 |
| publicationDate |
2016-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016175451-A1 |
| titleOfInvention |
Active principle for mitigating undesired medical conditions |
| abstract |
A composition for treating or preventing inflammatory-related conditions includes as an active principle a carrier which exhibits a plurality of a scavenger structure capable of mitigating the activity of a mediator of inflammatory-related conditions. The scavenger structure includes a nucleophilic centre complying with the formula X 1 (—R″—)(—R′) m H n where: a) X 1 is a single-bonded heteroatom selected amongst N, O and S and exhibits a free electron pair; b) m is 0 or 1 and n is 1 or 2; c) -R″- is a bivalent organic group providing attachment to the carrier via one of its free valences and to X 1 at the other free valence; and d) R′- is a monovalent organic group attached to the X 1 via its free valence. A method for treating or preventing inflammatory-related conditions in an individual suffering from such conditions includes: providing the composition; and contacting the mediator within or separate from the individual. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111225561-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020527606-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019016189-A1 |
| priorityDate |
2011-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |